Profitability & MarginsSustained high gross and net margins indicate durable pricing power and efficient biologics manufacturing. These margins support reinvestment in R&D and manufacturing, help absorb pricing/reimbursement pressure, and underpin long-term free cash generation.
Cash Generation StrengthRobust FCF growth and strong cash conversion show the business reliably turns earnings into cash. This improves resilience to funding needs, supports capex/R&D, dividends or selective M&A, and provides flexibility through industry cycles over months to years.
Balanced Capital Structure & ROEModerate leverage combined with a ~15.5% ROE signals effective use of equity and financial discipline. A balanced capital mix supports strategic investment while limiting refinancing strain, preserving optionality for growth or defensive spending.